KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Recursion Pharmaceuticals (RXRX) Tax Rate (2023 - 2025)

Historic Tax Rate for Recursion Pharmaceuticals (RXRX) over the last 3 years, with Q3 2025 value amounting to 0.0%.

  • Recursion Pharmaceuticals' Tax Rate rose 1700.0% to 0.0% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.02%, marking a year-over-year decrease of 13400.0%. This contributed to the annual value of 0.24% for FY2024, which is 9800.0% down from last year.
  • Recursion Pharmaceuticals' Tax Rate amounted to 0.0% in Q3 2025, which was up 1700.0% from 0.08% recorded in Q1 2025.
  • In the past 5 years, Recursion Pharmaceuticals' Tax Rate ranged from a high of 4.19% in Q4 2023 and a low of 0.17% during Q3 2024
  • Its 3-year average for Tax Rate is 0.78%, with a median of 0.08% in 2025.
  • Per our database at Business Quant, Recursion Pharmaceuticals' Tax Rate plummeted by -41900bps in 2024 and then soared by 1700bps in 2025.
  • Over the past 3 years, Recursion Pharmaceuticals' Tax Rate (Quarter) stood at 4.19% in 2023, then plummeted by -100bps to 0.0% in 2024, then surged by 53bps to 0.0% in 2025.
  • Its Tax Rate stands at 0.0% for Q3 2025, versus 0.08% for Q1 2025 and 0.0% for Q4 2024.